GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » Cash And Cash Equivalents

Organon Pharma Indonesia PT (ISX:SCPI) Cash And Cash Equivalents : Rp0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT Cash And Cash Equivalents?


Organon Pharma Indonesia PT Cash And Cash Equivalents Historical Data

The historical data trend for Organon Pharma Indonesia PT's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT Cash And Cash Equivalents Chart

Organon Pharma Indonesia PT Annual Data
Trend
Cash And Cash Equivalents

Organon Pharma Indonesia PT Quarterly Data
Cash And Cash Equivalents

Organon Pharma Indonesia PT Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.


Organon Pharma Indonesia PT  (ISX:SCPI) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.


Organon Pharma Indonesia PT Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines